Skip to content
Back to search

Belgium – Various medicinal products – Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa

IMELDA VZWBelgiumPublished on Nov 02, 2026
28 days left

Description

Biosimilars: Infliximab IV, Tocilizumab IV and SC, Denosumab SC, Epoetin alfa

CPV codes

Various medicinal products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders